Companies: 10,795·Total market cap: $144.5T
Purple Biotech Ltd.

Purple Biotech Ltd.

PPBTNASDAQHealthcare● Active
$2.89
$-0.08(-2.69%)
Market Cap$399063
P/E Ratio—
52W High$29
52W Low$2.52
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Purple Biotech Ltd. (PPBT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PPBT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-9933.94ppbt eps ttm · ppbt earnings per shareEarnings history
PE Ratio (TTM)—ppbt pe ratio ttm · ppbt price to earningsPE Ratio deep dive
Revenue (TTM)0.00ppbt revenue ttm · ppbt annual revenueFull revenue history
Dividend YieldNo Dividenddoes ppbt pay dividends · ppbt dividend yieldDividend history
Shares Outstanding2,400ppbt shares outstanding · ppbt floatShares outstanding history
Next EarningsAug 5, 2026Est.ppbt earnings date · ppbt next earningsEarnings history

Explore Purple Biotech Ltd. Data

ppbt stock data · financials
Market Cap$396,301ppbt market cap · ppbt valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes purple biotech ltd. pay dividends · ppbt dividend yield
Revenue—purple biotech ltd. annual revenue · ppbt revenue
EarningsEPS $-11080.00-24967.87%ppbt earnings · ppbt eps
PE Ratio—ppbt pe ratio · ppbt price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
purple biotech ltd. revenue · ppbt revenue 2025
FY 2025Net Income-$26.4M▼ 264.45% YoY
202320242025
purple biotech ltd. net income · ppbt profit 2025
FY 2025EPS$-11080.00▼ 24967.87% YoY
202320242025
ppbt eps · purple biotech ltd. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$26.2MEPS: $-9933.94View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis ppbt a buy · ppbt analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$2.89Current
$—Avg Target
$—High
ppbt price target · ppbt 12 month forecast

Total: 2 · Buy rate: 100.0%

Stock Performance

Full History
1D-3.37%
1W-1.71%
1M-30.51%
3M-39.96%
YTD-56.32%
1Y-89.00%
5Y-99.72%

About Purple Biotech Ltd.

CEOGil Efron
IPO DateNov 20, 2015
Employees9
CountryIL
Websitepurple-biotech.com

Purple Biotech Ltd. a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, …

BiotechnologyHealthcareNASDAQADRIL

what is purple biotech ltd. · ppbt stock overview · purple biotech ltd. company profile · who is purple biotech ltd. ceo · ppbt NASDAQ · purple biotech ltd. headquarters · purple biotech ltd. business segments

About Stock Overview & Key Data

Purple Biotech Ltd. (PPBT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 20, 2015. As of the latest trading session, PPBT stock price is $2.89, with a market capitalization of $396,301. The stock has returned -89.00% over the past 12 months and -56.32% year-to-date.

According to 2 Wall Street analysts, the consensus rating for Purple Biotech Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Purple Biotech Ltd. reported revenue of — and net income of -$26.4M. For detailed data — including Purple Biotech Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Purple Biotech Ltd. (PPBT) stock price is $2.89. The stock is traded on NASDAQ under the ticker symbol PPBT. The 52-week range is $2.52 – $29.00.

PPBT stock pricePPBT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice